guest ::
| Home > Publications Database > Inhibition of the MID1 protein complex: a novel approach targeting APP protein synthesis. > print |
| Home > Publications Database > Inhibition of the MID1 protein complex: a novel approach targeting APP protein synthesis. > print |
| 001 | 140621 | ||
| 005 | 20240430120009.0 | ||
| 024 | 7 | _ | |a 10.1038/s41420-017-0003-8 |2 doi |
| 024 | 7 | _ | |a pmid:29531801 |2 pmid |
| 024 | 7 | _ | |a pmc:PMC5841321 |2 pmc |
| 024 | 7 | _ | |a altmetric:32357431 |2 altmetric |
| 037 | _ | _ | |a DZNE-2020-06943 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Matthes, Frank |0 P:(DE-2719)2810945 |b 0 |e First author |
| 245 | _ | _ | |a Inhibition of the MID1 protein complex: a novel approach targeting APP protein synthesis. |
| 260 | _ | _ | |a London |c 2018 |b Nature Publishing Group |
| 264 | _ | 1 | |3 online |2 Crossref |b Springer Science and Business Media LLC |c 2018-01-29 |
| 264 | _ | 1 | |3 print |2 Crossref |b Springer Science and Business Media LLC |c 2018-12-01 |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1714467224_8222 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 520 | _ | _ | |a Alzheimer's disease (AD) is characterized by two neuropathological hallmarks: senile plaques, which are composed of amyloid-β (Aβ) peptides, and neurofibrillary tangles, which are composed of hyperphosphorylated tau protein. Aβ peptides are derived from sequential proteolytic cleavage of the amyloid precursor protein (APP). In this study, we identified a so far unknown mode of regulation of APP protein synthesis involving the MID1 protein complex: MID1 binds to and regulates the translation of APP mRNA. The underlying mode of action of MID1 involves the mTOR pathway. Thus, inhibition of the MID1 complex reduces the APP protein level in cultures of primary neurons. Based on this, we used one compound that we discovered previously to interfere with the MID1 complex, metformin, for in vivo experiments. Indeed, long-term treatment with metformin decreased APP protein expression levels and consequently Aβ in an AD mouse model. Importantly, we have initiated the metformin treatment late in life, at a time-point where mice were in an already progressed state of the disease, and could observe an improved behavioral phenotype. These findings together with our previous observation, showing that inhibition of the MID1 complex by metformin also decreases tau phosphorylation, make the MID1 complex a particularly interesting drug target for treating AD. |
| 536 | _ | _ | |a 342 - Disease Mechanisms and Model Systems (POF3-342) |0 G:(DE-HGF)POF3-342 |c POF3-342 |f POF III |x 0 |
| 542 | _ | _ | |i 2018-01-29 |2 Crossref |u http://creativecommons.org/licenses/by/4.0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, |
| 700 | 1 | _ | |a Hettich, Moritz M |0 P:(DE-2719)2380493 |b 1 |
| 700 | 1 | _ | |a Schilling, Judith |0 P:(DE-2719)2810643 |b 2 |
| 700 | 1 | _ | |a Flores-Dominguez, Diana |0 P:(DE-2719)9000076 |b 3 |
| 700 | 1 | _ | |a Blank, Nelli |0 P:(DE-2719)2811722 |b 4 |
| 700 | 1 | _ | |a Wiglenda, Thomas |b 5 |
| 700 | 1 | _ | |a Buntru, Alexander |b 6 |
| 700 | 1 | _ | |a Wolf, Hanna |0 P:(DE-2719)2630412 |b 7 |
| 700 | 1 | _ | |a Weber, Stephanie |0 P:(DE-2719)2662310 |b 8 |
| 700 | 1 | _ | |a Vorberg, Ina |0 P:(DE-2719)2481765 |b 9 |
| 700 | 1 | _ | |a Dagane, Alina |b 10 |
| 700 | 1 | _ | |a Dittmar, Gunnar |b 11 |
| 700 | 1 | _ | |a Wanker, Erich |b 12 |
| 700 | 1 | _ | |a Ehninger, Dan |0 P:(DE-2719)2289209 |b 13 |
| 700 | 1 | _ | |a Krauß, Sybille |0 P:(DE-2719)2421562 |b 14 |e Last author |u dzne |
| 773 | 1 | 8 | |a 10.1038/s41420-017-0003-8 |b : Springer Science and Business Media LLC, 2018-01-29 |n 1 |p 4 |3 journal-article |2 Crossref |t Cell Death Discovery |v 4 |y 2018 |x 2058-7716 |
| 773 | _ | _ | |a 10.1038/s41420-017-0003-8 |g Vol. 4, no. 1, p. 4 |0 PERI:(DE-600)2842546-7 |n 1 |q 4:1<4 |p 4 |t Cell death discovery |v 4 |y 2018 |x 2058-7716 |
| 856 | 4 | _ | |y OpenAccess |u https://pub.dzne.de/record/140621/files/DZNE-2020-06943.pdf |
| 856 | 4 | _ | |y OpenAccess |x pdfa |u https://pub.dzne.de/record/140621/files/DZNE-2020-06943.pdf?subformat=pdfa |
| 856 | 7 | _ | |2 Pubmed Central |u http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5841321 |
| 909 | C | O | |o oai:pub.dzne.de:140621 |p openaire |p open_access |p VDB |p driver |p dnbdelivery |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 0 |6 P:(DE-2719)2810945 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 1 |6 P:(DE-2719)2380493 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 2 |6 P:(DE-2719)2810643 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 3 |6 P:(DE-2719)9000076 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 4 |6 P:(DE-2719)2811722 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 7 |6 P:(DE-2719)2630412 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 8 |6 P:(DE-2719)2662310 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 9 |6 P:(DE-2719)2481765 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 13 |6 P:(DE-2719)2289209 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 14 |6 P:(DE-2719)2421562 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Erkrankungen des Nervensystems |1 G:(DE-HGF)POF3-340 |0 G:(DE-HGF)POF3-342 |3 G:(DE-HGF)POF3 |2 G:(DE-HGF)POF3-300 |4 G:(DE-HGF)POF |v Disease Mechanisms and Model Systems |x 0 |
| 914 | 1 | _ | |y 2018 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2023-03-31 |
| 915 | _ | _ | |a Creative Commons Attribution CC BY (No Version) |0 LIC:(DE-HGF)CCBYNV |2 V:(DE-HGF) |b DOAJ |d 2021-02-14T16:19:13Z |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2023-03-31 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1190 |2 StatID |b Biological Abstracts |d 2023-03-31 |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b CELL DEATH DISCOV : 2021 |d 2023-03-31 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |d 2023-03-31 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2023-03-31 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0501 |2 StatID |b DOAJ Seal |d 2021-02-14T16:19:13Z |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0500 |2 StatID |b DOAJ |d 2021-02-14T16:19:13Z |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2023-03-31 |
| 915 | _ | _ | |a Fees |0 StatID:(DE-HGF)0700 |2 StatID |d 2023-03-31 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2023-03-31 |
| 915 | _ | _ | |a OpenAccess |0 StatID:(DE-HGF)0510 |2 StatID |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b DOAJ : Blind peer review |d 2021-02-14T16:19:13Z |
| 915 | _ | _ | |a Article Processing Charges |0 StatID:(DE-HGF)0561 |2 StatID |d 2023-03-31 |
| 915 | _ | _ | |a IF >= 5 |0 StatID:(DE-HGF)9905 |2 StatID |b CELL DEATH DISCOV : 2021 |d 2023-03-31 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2023-03-31 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2023-03-31 |
| 920 | 1 | _ | |0 I:(DE-2719)1011006 |k AG Krauß |l Regulatory RNA-protein interaction in neurodegenerative diseases |x 0 |
| 920 | 1 | _ | |0 I:(DE-2719)1013005 |k AG Ehninger |l Translational Biogerontology |x 1 |
| 920 | 1 | _ | |0 I:(DE-2719)1013004 |k AG Vorberg |l Prion Cell Biology |x 2 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a UNRESTRICTED |
| 980 | _ | _ | |a I:(DE-2719)1011006 |
| 980 | _ | _ | |a I:(DE-2719)1013005 |
| 980 | _ | _ | |a I:(DE-2719)1013004 |
| 980 | 1 | _ | |a FullTexts |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1002/ca.980080612 |2 Crossref |o 10.1002/ca.980080612 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.7326/0003-4819-113-6-429 |2 Crossref |o 10.7326/0003-4819-113-6-429 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1192/bjp.157.1.72 |2 Crossref |o 10.1192/bjp.157.1.72 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1073/pnas.94.1.298 |2 Crossref |o 10.1073/pnas.94.1.298 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1007/s00702-004-0221-0 |2 Crossref |o 10.1007/s00702-004-0221-0 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1159/000067425 |2 Crossref |o 10.1159/000067425 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1073/pnas.0912793107 |2 Crossref |o 10.1073/pnas.0912793107 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1038/ng762 |2 Crossref |o 10.1038/ng762 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1073/pnas.1100131108 |2 Crossref |o 10.1073/pnas.1100131108 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1101/gad.887201 |2 Crossref |o 10.1101/gad.887201 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1074/jbc.M111.224451 |2 Crossref |o 10.1074/jbc.M111.224451 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1038/ncomms2514 |2 Crossref |o 10.1038/ncomms2514 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1007/s00439-007-0456-6 |2 Crossref |o 10.1007/s00439-007-0456-6 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1186/1471-2407-14-52 |2 Crossref |o 10.1186/1471-2407-14-52 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1371/journal.pone.0102420 |2 Crossref |o 10.1371/journal.pone.0102420 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1186/1476-4598-13-146 |2 Crossref |o 10.1186/1476-4598-13-146 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1111/j.1432-1033.1969.tb00629.x |2 Crossref |o 10.1111/j.1432-1033.1969.tb00629.x |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1016/j.cell.2006.01.016 |2 Crossref |o 10.1016/j.cell.2006.01.016 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1042/BST20120080 |2 Crossref |o 10.1042/BST20120080 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1074/jbc.M110.100420 |2 Crossref |o 10.1074/jbc.M110.100420 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1111/j.1532-5415.2012.03916.x |2 Crossref |o 10.1111/j.1532-5415.2012.03916.x |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.2337/dc13-0229 |2 Crossref |o 10.2337/dc13-0229 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1016/j.neuropharm.2011.01.033 |2 Crossref |o 10.1016/j.neuropharm.2011.01.033 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1073/pnas.0807991106 |2 Crossref |o 10.1073/pnas.0807991106 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1016/j.pbb.2012.03.002 |2 Crossref |o 10.1016/j.pbb.2012.03.002 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.3233/JAD-141332 |2 Crossref |o 10.3233/JAD-141332 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1016/j.bbamcr.2015.01.017 |2 Crossref |o 10.1016/j.bbamcr.2015.01.017 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1371/journal.pone.0005088 |2 Crossref |o 10.1371/journal.pone.0005088 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1007/s00216-015-8595-4 |2 Crossref |o 10.1007/s00216-015-8595-4 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1038/nprot.2007.261 |2 Crossref |o 10.1038/nprot.2007.261 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1038/nbt.1511 |2 Crossref |o 10.1038/nbt.1511 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1073/pnas.0910723107 |2 Crossref |o 10.1073/pnas.0910723107 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1038/nsmb.1437 |2 Crossref |o 10.1038/nsmb.1437 |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|